
The majority of VPs of Investor Relations at Hikma Pharmaceuticals believe they're compensated fairly. 100% of VPs of Investor Relations at Hikma Pharmaceuticals say they receive annual bonuses, and the majority (67%) are satisfied with their benefits. See more compensation ratings at Hikma Pharmaceuticals